Pfizer Inc. is expected to file its next quarterly report (Form 10-Q), for the period ending about Sept. 27, 2026, between Nov. 2, 2026 and Nov. 4, 2026, based on its last 8 10-Q filings. The SEC deadline for a large accelerated filer is Nov. 6, 2026.
How the next-report window is calculated
Pfizer Inc.'s most recent periodic report on file is a Form 10-Q for the period ended June 28, 2026, filed Aug. 4, 2026. Its fiscal year ends around Dec. 31, so the next period should close about Sept. 27, 2026, and that report is a Form 10-Q.
SEC rules give a large accelerated filer 40 days after period end to file a 10-Q, which lands on Nov. 6, 2026 after moving off weekends and federal holidays. Over its last 8 10-Qs, Pfizer Inc. filed between 36 and 38 days after period end (median 37 days), which gives the expected window above. Period ends are estimated from the company's own calendar and may shift by a few days in 52/53-week fiscal years.
Recent filings by Pfizer Inc.
| Filed | Form | What it is | Document |
|---|---|---|---|
| N-PX | Annual report of proxy votes cast | Open N-PX filed 2026-08-31 · Index 0000078003-26-000111 | |
| 10-Q | Quarterly report with unaudited financial statements for the period ended June 28, 2026 | Open 10-Q filed 2026-08-04 · Index 0000078003-26-000095 | |
| 8-K | Released earnings or financial results | Open 8-K filed 2026-08-04 · Index 0000078003-26-000094 | |
| 8-K | Information shared under Regulation FD | Open 8-K filed 2026-06-18 · Index 0000078003-26-000087 | |
| 8-K | Executive or board change, or executive pay arrangement | Open 8-K filed 2026-06-18 · Index 0000078003-26-000085 | |
| 11-K | Annual report of an employee stock purchase or savings plan | Open 11-K filed 2026-06-16 · Index 0000078003-26-000080 | |
| 11-K | Annual report of an employee stock purchase or savings plan | Open 11-K filed 2026-06-16 · Index 0000078003-26-000078 | |
| 13G/A | Amendment to a passive-ownership (13G) report | Open SCHEDULE 13G/A filed 2026-05-12 · Index 0000078003-26-000067 | |
| S-8 | Registration of shares for employee benefit plans | Open S-8 filed 2026-05-05 · Index 0000078003-26-000058 | |
| 10-Q | Quarterly report with unaudited financial statements for the period ended March 29, 2026 | Open 10-Q filed 2026-05-05 · Index 0000078003-26-000054 | |
| 8-K | Released earnings or financial results | Open 8-K filed 2026-05-05 · Index 0000078003-26-000053 | |
| 13G | Ownership above 5% by a passive or institutional investor | Open SCHEDULE 13G filed 2026-05-01 · Index 0002100119-26-001294 | |
| 8-K | Reported shareholder vote results | Open 8-K filed 2026-04-27 · Index 0000078003-26-000044 | |
| 13G/A | Amendment to a passive-ownership (13G) report | Open SCHEDULE 13G/A filed 2026-03-27 · Index 0000102909-26-002101 | |
| ARS | Annual report delivered to shareholders | Open ARS filed 2026-03-12 · Index 0000078003-26-000038 | |
| DEFA14A | Additional proxy soliciting materials | Open DEFA14A filed 2026-03-12 · Index 0000078003-26-000035 | |
| DEF 14A | Definitive proxy statement for a shareholder meeting | Open DEF 14A filed 2026-03-12 · Index 0000078003-26-000033 | |
| 10-K | Annual report with audited financial statements for the period ended Dec. 31, 2025 | Open 10-K filed 2026-02-26 · Index 0000078003-26-000026 | |
| 13D/A | Amendment to an active-ownership (13D) report | Open SCHEDULE 13D/A filed 2026-02-13 · Index 0000078003-26-000022 | |
| 13G/A | Amendment to a passive-ownership (13G) report | Open SCHEDULE 13G/A filed 2026-02-13 · Index 0000078003-26-000020 | |
| 13G/A | Amendment to a passive-ownership (13G) report | Open SCHEDULE 13G/A filed 2026-02-13 · Index 0000078003-26-000018 | |
| 8-K | Released earnings or financial results | Open 8-K filed 2026-02-03 · Index 0000078003-26-000005 | |
| 8-K | Information shared under Regulation FD | Open 8-K filed 2025-12-16 · Index 0000078003-25-000167 | |
| 8-K | Other events the company chose to report | Open 8-K filed 2025-11-21 · Index 0001193125-25-291406 | |
| 8-K | Other events the company chose to report | Open 8-K filed 2025-11-13 · Index 0000078003-25-000159 |
What Pfizer Inc.'s 8-Ks were about in the past year
Pfizer Inc. filed 10 Form 8-K current reports between Oct. 17, 2025 and Oct. 16, 2026. Each report lists the item numbers it covers; the counts below show how often each item appeared.
| Item | Meaning | Times |
|---|---|---|
| 9.01 | Financial Statements and Exhibits | 7 |
| 2.02 | Results of Operations and Financial Condition | 4 |
| 7.01 | Regulation FD Disclosure | 2 |
| 8.01 | Other Events | 2 |
| 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1 |
| 5.07 | Submission of Matters to a Vote of Security Holders | 1 |